Evidence map›Paper›PMID 39146231›Full record

ArticlePLoS neglected tropical diseases2024

A standardized clinical database for research in Chagas disease: The NHEPACHA network.

Adriana González Martínez, Irene Losada-Galván, Juan Carlos Gabaldón-Figueira, Nieves Martínez-Peinado, Roberto Magalhães Saraiva, Marisa Liliana Fernández, Janine M Ramsey, Oscar Noya-González, Belkisyole Alarcón de Noya, Alejandro Gabriel Schijman and 8 more

Abstract read
In one paragraph

Article in PLoS neglected tropical diseases, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Review
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

18 authors.

Adriana González MartínezDepartamento de Investigación, Salvando Latidos A.C., Guadalajara, Mexico.
Irene Losada-GalvánBarcelona Institute for Global Health (ISGlobal), Hospital Clínic-Universitat de Barcelona, Barcelona, Spain.
Juan Carlos Gabaldón-FigueiraBarcelona Institute for Global Health (ISGlobal), Hospital Clínic-Universitat de Barcelona, Barcelona, Spain.ORCID https://orcid.org/0000-0002-2525-0263
Nieves Martínez-PeinadoBarcelona Institute for Global Health (ISGlobal), Hospital Clínic-Universitat de Barcelona, Barcelona, Spain.
Roberto Magalhães SaraivaEvandro Chagas National Institute of Infectious Diseases, Fundação Oswaldo Cruz, Rio de Janeiro, Brasil.ORCID https://orcid.org/0000-0002-2263-4261
Marisa Liliana FernándezInstituto Nacional de Parasitología Dr M. Fatala Chabén, Administración Nacional de Laboratorios e Institutos de Salud Dr C. Malbrán, Ministerio de Salud, Buenos Aires, Argentina.
Janine M RamseyCentro Regional de Investigación en Salud Pública (CRISP), Instituto Nacional de Salud Pública (INSP), Tapachula, Chiapas, México.
Oscar Noya-GonzálezCátedra de Parasitología, Escuela "Luís Razetti" Facultad de Medicina, Universidad Central de Venezuela, Caracas, Venezuela.
Belkisyole Alarcón de NoyaInstituto de Medicina Tropical, Facultad de Medicina, Universidad Central de Venezuela, Caracas, Venezuela.
Alejandro Gabriel SchijmanLaboratorio de Biología Molecular de la Enfermedad de Chagas, Instituto de Investigaciones en Ingeniería Genética y Biología Molecular "Dr. Héctor N. Torres"-INGEBI-CONICET, Buenos Aires, Argentina.
Soledad BerónFundación Mundo Sano, Buenos Aires, Argentina.
Marcelo AbrilFundación Mundo Sano, Buenos Aires, Argentina.
Joaquim GascónBarcelona Institute for Global Health (ISGlobal), Hospital Clínic-Universitat de Barcelona, Barcelona, Spain.
Sergio Sosa-EstaniDrugs for Neglected Diseases Initiative (DNDi), Geneva, Switzerland.
María Jesús PinazoDrugs for Neglected Diseases Initiative (DNDi), Geneva, Switzerland.
Julio Alonso-PadillaBarcelona Institute for Global Health (ISGlobal), Hospital Clínic-Universitat de Barcelona, Barcelona, Spain.ORCID https://orcid.org/0000-0003-4466-7969
Alejandro Marcel Hasslocher-MorenoEvandro Chagas National Institute of Infectious Diseases, Fundação Oswaldo Cruz, Rio de Janeiro, Brasil.
NHEPACHA network (Nuevas Herramientas para el diagnóstico y la evaluación del paciente con enfermedad de Chagas)

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The NHEPACHA Iberoamerican Network, founded on the initiative of a group of researchers from Latin American countries and Spain, aims to establish a research framework for Chagas disease that encompasses diagnosis and treatment. For this purpose, the network has created a questionnaire to gather relevant data on epidemiological, clinical, diagnostic, and therapeutic aspects of the disease. This questionnaire was developed based on a consensus of expert members of the network, with the intention of collecting high-quality standardized data, which can be used interchangeably by the different research centers that make up the NHEPACHA network. Furthermore, the network intends to offer a clinical protocol that can be embraced by other researchers, facilitating comparability among published studies, as well as the development of therapeutic response and progression markers.

Indexed as

Chagas DiseaseBiomedical ResearchDatabases, FactualHumansLatin AmericaSpainSurveys and Questionnaires

Identifiers

PMID39146231
PMCPMC11326575

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.